Vlado Perkovic's Publications

About Vlado Perkovic's Publications

Board Member
  • MBBS,
  • PhD,
  • FASN,
  • FRACP
  • Worldwide access to treatment for end-stage kidney disease: a systematic review

    The Lancet Date published:
  • Interventions for lowering plasma homocysteine levels in kidney transplant recipients

    Cochrane Database of Systematic Reviews Date published:
  • Design and participant baseline characteristics of ‘A C linical T rial of IntensiVE D ialysis’: The ACTIVE D ialysis S tudy

    Nephrology Date published:
  • EFFECTS OF THE MEDITERRANEAN DIET ON CARDIOVASCULAR OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS

    Journal of the American College of Cardiology Date published:
  • Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials

    The Lancet Date published:
  • The rationale and design of the B eta-blocker to LO wer CA rdiovascular D ialysis E vents ( BLOCADE ) F easibility S tudy

    Nephrology Date published:
  • Blood Pressure Lowering in Type 2 Diabetes

    JAMA Date published:
  • The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study

    BMJ Date published:
  • Co-payments for health care: what is their real cost?

    Australian Health Review Date published:
  • Fibrates: Risk Benefits and Role in Treating Dyslipidemias

    Contemporary Endocrinology Date published:
  • Association between Serum Alkaline Phosphatase and Primary Resistance to Erythropoiesis Stimulating Agents in Chronic Kidney Disease: A Secondary Analysis of the HERO Trial

    Canadian Journal of Kidney Health and Disease Date published:
  • A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial

    American Journal of Kidney Diseases Date published:
  • Clinical characteristics of IgA nephropathy associated with low complement 4 levels

    Renal Failure Date published:
  • Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes

    Diabetes Care Date published:
  • Interventions for preventing intradialytic hypotension in haemodialysis patients

    Cochrane Database of Systematic Reviews Date published:
  • Optimal targets for blood pressure control in chronic kidney disease

    Current Opinion in Nephrology and Hypertension Date published: